logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8057810 B1

PDFFull Text
Date of Patent:
Nov. 15, 2011

Filed:

Mar. 02, 2007

Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application

Applicants:

Vladimir Khatskelevich Khavinson, St. Petersburg, RU;

Evgeny Iosifovich Grigoriev, St. Petersburg, RU;

Vladimir Victorivich Malinin, St. Petersburg, RU;

Galina Anatolievna Ryzhak, St. Petersburg, RU;

Inventors:

Vladimir Khatskelevich Khavinson, St. Petersburg, RU;

Evgeny Iosifovich Grigoriev, St. Petersburg, RU;

Vladimir Victorivich Malinin, St. Petersburg, RU;

Galina Anatolievna Ryzhak, St. Petersburg, RU;

Assignee:

Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides”, Saint-Petersburg, RU;

Attorney:

Leydig, Voit & Mayer, Ltd.

Primary Examiner:

Jeffrey E Russel

Int. Cl.
CPC ...
A61K 38/06 (2006.01); C07K 5/093 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed is a pharmaceutical composition for the prevention and correction of age-related disorders of cellular and humoral immunity and having an immunogeroprotective effect. The pharmaceutical composition includes a peptide glutamyl-aspartyl-proline with general formula H-Glu-Asp-Pro-OH sequence 1 [SEQ ID NO:1]. The pharmaceutical composition can be in the form suitable for parenteral administration. Also disclosed is a method of prevention and/or correction of age-related disorders of cellular and humoral immunity by stimulating the processes of lymphocytes proliferation and differentiation, such method consisting in the administration to a patient of a pharmaceutical composition containing an effective amount of peptide glutamyl-aspartyl-proline with general formula: H-Glu-Asp-Pro-OH sequence 1 [SEQ ID NO:1] in the dose of 0.01-100 μg/kg of body weight as an active base at least once a day during a period necessary for attaining a therapeutic effect.

Find Patent Forward Citations

Khavinson, Vladimir. (2011). Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application (U.S. Patent No. 8057810). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8057810

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…